National Institute of Child Health and Human Development (NICHD)
Fetal Diagnosis and Therapy in the Third Millennium
September 22 – 23, 2000 • Leuven, Belgium
Agenda
| Friday, September 22 |
| Welcome S Groft, Bethesda (USA) & F A Van Assche, KU Leuven H. Hyatt-Knorr, ORD, NIH |
| Prenatal Diagnosis and Screening, Invasive Procedures Chairs: F de la Cruz, Bethesda, MD (USA) & JP Fryns & E Gratacos, Leuven (BE) |
| Biochemical screening for Down syndrome H Cuckle, London (UK) |
| Early ultrasound as a screening for fetal malformations K Nicolaides, London (UK) |
| The 1990s: Chorion villus sampling and amniocentesis:
Early, late or … in between? L Jackson, Philadelphia (USA) |
| Societal aspects of genetic screening and diagnosis U Nicolini, Milano (IT) |
| Wider issues in genetic testing and screening P Harper, Cardiff (UK) |
| What does society expect from and is willing to accept:
The case of early anomaly screening of fetuses? P Koch, Swiss Federal Office of Social Security, Bern (CH) |
| Chairs: Y Ville, Paris (F), M Evans, Detroit (USA) & M Johnson, Philadelphia (USA) |
| Embryo-reduction and selective feticide M Evans, Detroit (USA) |
| Invasive testing in multiplets L De Catte, Brussels (BE) |
| Embryoscopy Y Ville, Paris (F) |
| The invasiveness of ultrasound based procedures:
Instrumentation, complications related to techniques used
and the fetal condition, learning curve, and training. C Weiner, Baltimore (USA) |
| The Eurofoetus-Registry of fetoscopic procedures E Gratacos, Leuven (B) |
| Latrogenic ruptured membranes: Healing dynamics
and potential therapy J Deprest, Leuven (B) |
| Amniocentesis in preterm labour and PPROM Y Ville, Paris (F) |
| Intra-Uterine Transfusion Chairs: U Nicolini, Milano (I) C Weiner, Baltimore (USA) |
| Severe fetal anemia after 32 weeks: Intra-uterine
transfusion or neonatal intensive care unit ? F Vandenbussche, Leiden (NL) & Leuven (B) |
| Accuracy of invasive versus non-invasive testing
for severe fetal anemia D Oepkes, Toronto (CAN) |
| Non Rh-immunisation K Moise, Chapel Hill (USA) |
| New Pathways and Insights in Fetal Diagnosis and Therapy Chairs: T-H Bui, Stockholm (S), F de la Cruz, Bethesda, MD (USA) & J J Cassiman, Leuven (B) |
| Non-invasive diagnosis: Fetal cells in maternal blood D Bianchi, Boston (USA) |
| In utero gene therapy C Coutelle, London (UK) |
| In utero stem cell transplantation T-H Bui, Stockholm (S) |
| The potential of embryonic stem cells in fetal therapy M Westgren, Stockholm (S) |
| Operative Fetoscopy and Fetal Surgery Chairs: F Chervenak, New York (USA), K Hecher, Hamburg (D) & H Devlieger, Leuven (B) |
| Ethical Aspects
Fetal nociception and stress responsiveness |
| Ethics of in utero surgery M Whittle, Birmingham (UK) |
| Obstetrical Endoscopy
Twin-to-Twin Transfusion Syndrome |
| Amniodrainage and septostomy in TTTS C Hubinont, Brussels (B) |
| Selective feticide in monochorionic twins with
one non-viable foetus J Deprest, Leuven (B) |
| Congenital diaphragmatic hernia Chairs: M Harrison, San Francisco (USA), T Lerut, Leuven (B) & M Johnson, Philadelphia (USA) |
Congenital diaphragmatic hernia as part of malformation
syndromes J P Fryns, Leuven (BE) |
| Results from post-natal treatment for congenital diaphragmatic
hernia and strategy to identify candidates for in utero surgery T Tracy, Providence (USA) |
| In utero imaging for diaphragmatic hernia: Prenatal
prognostic indicators M Dommergues, Paris (F) |
| Requirements for in utero surgery: Diaphragmatic
hernia as a model F Luks, Providence (USA) |
| Perinatal hormonal ‘surgery’, can we identify the
proper patient on an individual base ? D Tibboel, Rotterdam (NL) |
| In utero surgery for CDH – criteria and clinical results M Harrison, San Francisco (USA) |
| Lung lesions and lower urinary tract obstruction
Lung lesions: Natural history, selection criteria, and
in utero surgery M Harrison, San Francisco (USA) |
| Lower urinary tract obstruction:
Pathophysiology & new pathways in diagnosis and therapy M P Johnson, Philadelphia (USA) |
| In utero shunting: Selection criteria, results, and
outcome C Rodeck, London (UK) |
| Central nervous system Chairs: P Casaer, Leuven (B) & M Johnson, Philadelphia (USA) |
| Myelomeningocele and hydrocephalus:
Rationale, criteria and results for in utero surgery J Bruner, Nashville (USA) |
| The case for or against in utero surgery for neural
tube defects and hydrocephalus C Bannister, Manchester (UK) |
| Ethics of in utero surgery for non-lethal conditions F Chervenak, New York (USA) |
| Organisation of fetal medicine in a European perspective W Holzgreve, Basel (CH) |
 |
|
 |